These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25642985)

  • 1. Selective nonpeptidic fluorescent ligands for oxytocin receptor: design, synthesis, and application to time-resolved FRET binding assay.
    Karpenko IA; Margathe JF; Rodriguez T; Pflimlin E; Dupuis E; Hibert M; Durroux T; Bonnet D
    J Med Chem; 2015 Mar; 58(5):2547-52. PubMed ID: 25642985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective fluorescent nonpeptidic antagonists for vasopressin V₂ GPCR: application to ligand screening and oligomerization assays.
    Loison S; Cottet M; Orcel H; Adihou H; Rahmeh R; Lamarque L; Trinquet E; Kellenberger E; Hibert M; Durroux T; Mouillac B; Bonnet D
    J Med Chem; 2012 Oct; 55(20):8588-602. PubMed ID: 22984902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive and ligand-induced nuclear localization of oxytocin receptor.
    Kinsey CG; Bussolati G; Bosco M; Kimura T; Pizzorno MC; Chernin MI; Cassoni P; Novak JF
    J Cell Mol Med; 2007; 11(1):96-110. PubMed ID: 17367504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-resolved FRET binding assay to investigate hetero-oligomer binding properties: proof of concept with dopamine D1/D3 heterodimer.
    Hounsou C; Margathe JF; Oueslati N; Belhocine A; Dupuis E; Thomas C; Mann A; Ilien B; Rognan D; Trinquet E; Hibert M; Pin JP; Bonnet D; Durroux T
    ACS Chem Biol; 2015 Feb; 10(2):466-74. PubMed ID: 25350273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.
    Albizu L; Teppaz G; Seyer R; Bazin H; Ansanay H; Manning M; Mouillac B; Durroux T
    J Med Chem; 2007 Oct; 50(20):4976-85. PubMed ID: 17850055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A homogeneous G protein-coupled receptor ligand binding assay based on time-resolved fluorescence resonance energy transfer.
    Hu LA; Zhou T; Hamman BD; Liu Q
    Assay Drug Dev Technol; 2008 Aug; 6(4):543-50. PubMed ID: 18699727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red fluorescent turn-on ligands for imaging and quantifying G protein-coupled receptors in living cells.
    Karpenko IA; Kreder R; Valencia C; Villa P; Mendre C; Mouillac B; Mély Y; Hibert M; Bonnet D; Klymchenko AS
    Chembiochem; 2014 Feb; 15(3):359-63. PubMed ID: 24449564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescent ligands to investigate GPCR binding properties and oligomerization.
    Cottet M; Faklaris O; Falco A; Trinquet E; Pin JP; Mouillac B; Durroux T
    Biochem Soc Trans; 2013 Feb; 41(1):148-53. PubMed ID: 23356275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-resolved Förster resonance energy transfer-based technologies to investigate G protein-coupled receptor machinery: high-throughput screening assays and future development.
    Scholler P; Zwier JM; Trinquet E; Rondard P; Pin JP; Prézeau L; Kniazeff J
    Prog Mol Biol Transl Sci; 2013; 113():275-312. PubMed ID: 23244793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoselective Acylation of Hydrazinopeptides to Access Fluorescent Probes for Time-Resolved FRET Assays on GPCRs.
    Ramanoudjame SM; Esteoulle L; Riché S; Margathe JF; Durroux T; Karpenko IA; Bonnet D
    Methods Mol Biol; 2019; 1947():137-147. PubMed ID: 30969414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol-induced conformational changes in the oxytocin receptor.
    Muth S; Fries A; Gimpl G
    Biochem J; 2011 Aug; 437(3):541-53. PubMed ID: 21561435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homogeneous time-resolved fluorescence-based assay to screen for ligands targeting the growth hormone secretagogue receptor type 1a.
    Leyris JP; Roux T; Trinquet E; Verdié P; Fehrentz JA; Oueslati N; Douzon S; Bourrier E; Lamarque L; Gagne D; Galleyrand JC; M'kadmi C; Martinez J; Mary S; Banères JL; Marie J
    Anal Biochem; 2011 Jan; 408(2):253-62. PubMed ID: 20937574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docking ligands to vasopressin and oxytocin receptors via genetic algorithm.
    Politowska E; Drabik P; Kazmierkiewicz R; Ciarkowsk J
    J Recept Signal Transduct Res; 2002; 22(1-4):393-409. PubMed ID: 12503629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring Affinity of Ligands to the Oxytocin Receptor Using Radioligand Binding.
    Werry EL; Kassiou M
    Methods Mol Biol; 2022; 2384():231-245. PubMed ID: 34550578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of time resolved fluorescence resonance energy transfer-based assay for FXR antagonist discovery.
    Yu DD; Lin W; Chen T; Forman BM
    Bioorg Med Chem; 2013 Jul; 21(14):4266-78. PubMed ID: 23688559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-resolved FRET strategy to screen GPCR ligand library.
    Oueslati N; Hounsou C; Belhocine A; Rodriguez T; Dupuis E; Zwier JM; Trinquet E; Pin JP; Durroux T
    Methods Mol Biol; 2015; 1272():23-36. PubMed ID: 25563174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an extracellular segment of the oxytocin receptor providing agonist-specific binding epitopes.
    Hawtin SR; Howard HC; Wheatley M
    Biochem J; 2001 Mar; 354(Pt 2):465-72. PubMed ID: 11171127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Time-Resolved FRET Cell-Based Binding Assay for the Apelin Receptor.
    Valencia C; Dujet C; Margathe JF; Iturrioz X; Roux T; Trinquet E; Villa P; Hibert M; Dupuis E; Llorens-Cortes C; Bonnet D
    ChemMedChem; 2017 Jun; 12(12):925-931. PubMed ID: 28374567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-resolved FRET between GPCR ligands reveals oligomers in native tissues.
    Albizu L; Cottet M; Kralikova M; Stoev S; Seyer R; Brabet I; Roux T; Bazin H; Bourrier E; Lamarque L; Breton C; Rives ML; Newman A; Javitch J; Trinquet E; Manning M; Pin JP; Mouillac B; Durroux T
    Nat Chem Biol; 2010 Aug; 6(8):587-94. PubMed ID: 20622858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of BODIPY FL Thalidomide As a High-Affinity Fluorescent Probe for Cereblon in a Time-Resolved Fluorescence Resonance Energy Transfer Assay.
    Lin W; Li Y; Min J; Liu J; Yang L; Lee RE; Chen T
    Bioconjug Chem; 2020 Nov; 31(11):2564-2575. PubMed ID: 33070611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.